LRT Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,831
Closed -$496K 88
2023
Q4
$496K Sell
1,831
-4,412
-71% -$1.09M 0.47% 68
2023
Q3
$1.54M Sell
6,243
-981
-14% -$268K 1.06% 44
2023
Q2
$2.17M Sell
7,224
-2,378
-25% -$661K 1.6% 21
2023
Q1
$2.53M Buy
9,602
+3,970
+70% +$1.01M 1.9% 17
2022
Q4
$1.35M Sell
5,632
-2,622
-32% -$587K 0.78% 40
2022
Q3
$1.52M Buy
8,254
+122
+2% +$24.3K 1.03% 37
2022
Q2
$1.37M Buy
8,132
+4,206
+107% +$904K 1.03% 37
2022
Q1
$984K Buy
3,926
+1,317
+50% +$331K 0.63% 44
2021
Q4
$670K Buy
+2,609
New +$638K 0.51% 43

Other funds holding HCA

LRT Capital Management's HCA Position: Q1 2024 in Review

LRT Capital Management sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 1,831 shares — an estimated $496K sold.

LRT Capital Management first reported a position in HCA in Q4 2021 and held it in 9 quarters. The position peaked at $2.53M in Q1 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • LRT Capital Management reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
  • LRT Capital Management sold 1,831 HCA Healthcare shares in Q1 2024, an estimated $496K.
  • LRT Capital Management first reported a position in HCA Healthcare in Q4 2021 and held it in 9 quarters.
  • LRT Capital Management's HCA Healthcare position peaked at $2.53M in Q1 2023.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on LRT Capital Management's 13F filing for Q1 2024, filed 15 May 2024.